Yahoo India Web Search

Sign In

Search results

      • A collaborative research agreement was inked between the parties to develop oral medication through the discovery of small molecule inhibitors of Sclerostin, the Ahmedabad-based drug firm said in a regulatory filing. As per the agreement, CDRI and Zydus will jointly undertake preclinical research, it said.
      pharma.economictimes.indiatimes.com/news/mergers-and-acquisitions/zydus-ties-up-with-csir-cdri-to-develop-drug-for-ckd-induced-osteoporosis/113759973

      Novel Drugs India: Zydus ties up with CSIR-CDRI to develop ...

  2. People also ask

  3. pharma.economictimes.indiatimes.com › news › mergersNovel Drugs India: Zydus ties up with CSIR-CDRI to develop ...

    4 days ago · As per the agreement, CDRI and Zydus will jointly undertake preclinical research, it said. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets, it added.

  4. medicaldialogues.in › news › industryZydus, CSIR-CDRI Lucknow to develop drug for Chronic Kidney ...

    1 day ago · Under this agreement, CDRI and Zydus will jointly undertake preclinical research. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets. Chronic kidney disease (CKD) affects over 10% of the global population, posing significant health challenges.

  5. apacnewsnetwork.com › 2024 › 10Zydus and CSIR-CDRI join hands to develop drug for Chronic ...

    1 day ago · New Delhi: Zydus Lifesciences has tied up with Lucknow-based CSIR-Central Drug Research Institute (CDRI) to develop a drug for chronic kidney disease (CKD)-induced osteoporosis. As per the agreement, Zydus and CDRI will jointly undertake preclinical research on the drug.

  6. pib.gov.in › PressReleasePagePress Release:Press Information Bureau

    2 days ago · Under this agreement, CDRI and Zydus will jointly undertake preclinical research. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets.

  7. health.economictimes.indiatimes.com › newsZydus ties up with CSIR-CDRI to develop drug for CKD-induced ...

    4 days ago · New Delhi: Zydus Lifesciences on Friday said it has tied up with Lucknow-based CSIR-Central Drug Research Institute (CDRI) to develop a drug for chronic kidney disease-induced osteoporosis. As per the agreement, CDRI and Zydus will jointly undertake preclinical research, it said.

  8. timesofindia.indiatimes.com › city › lucknowCDRI: CDRI Unveils Protein-Drug Combination to Combat ...

    2 days ago · To develop oral medication through the discovery of small molecule inhibitors of sclerostin, CDRI and Zydus Lifesciences Ltd, Ahmedabad, have signed a collaborative research agreement, under which, both organisations will jointly undertake preclinical research and any drug candidate emerging from their efforts will be developed by Zydus for Indi...

  9. www.zeebiz.com › companies › news-zydus-ties-up-withZydus ties up with CSIR-CDRI to develop drug for CKD-induced ...

    5 days ago · As per the agreement, CDRI and Zydus will jointly undertake preclinical research, it said. Any drug candidate emerging from the efforts will be developed by Zydus for India and other markets, it added.